CDHR2 Antikörper (AA 151-250) (Cy7)

Produktnummer ABIN2178340

Produktdetails anti-CDHR2 Antikörper (Cy7)

Target: CDHR2 (Cadherin-Related Family Member 2 (CDHR2))

Bindungsspezifität: AA 151-250

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser CDHR2 Antikörper ist konjugiert mit Cy7

Applikation: Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunofluorescence (Cultured Cells) (IF (cc))

Homologie: Human,Mouse,Rat,Pig

Aufreinigung: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human PCLKC

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Haltbarkeit: 12 months

Details zu CDHR2

Target: CDHR2 (Cadherin-Related Family Member 2 (CDHR2))

Andere Bezeichnung: Pclkc (CDHR2 Produkte)

Synonyme: PCDH24 antikoerper, PCLKC antikoerper, cadherin related family member 2 antikoerper, CDHR2 antikoerper

Hintergrund:

Synonyms: FLJ20124, FLJ20383, MGC163154, PC LKC,PC-LKC, Protocadherin LKC.

Background: PCLKC (Protocadherin LKC) belongs to the protocadherin gene family, a subgroup of the cadherin superfamily. It is predominantly expressed in liver, kidney and colon tissues, and has a role in contact inhibition at the lateral surface of epithelial cells. It is a candidate tumor suppressor.